['A recent genome-wide association study identified the FUT2 secretor status and genotype defined by the single-nucleotide polymorphism rs601338 as potential genetic risk factor in primary sclerosing cholangitis (PSC), which significantly influences biliary bacterial composition.', 'To determine the impact of the rs601338-FUT2 genotype on frequency of biliary infections, development of dominant stenosis and liver-transplantation-free survival in patients with PSC.', 'Cohort study of 215 patients with PSC treated at our tertiary care centre with respect to their rs601338-FUT2 genotype. Results of endoscopic retrograde cholangiography and bile culture were analysed; 639 biliary samples were obtained, cultured and subjected to microbial analysis. Clinical and laboratory data were analysed using chart reviews.', 'For the rs601338-FUT2 genotype, 69 patients (32.1%) were found to be wildtype (GG), 97 (45.1%) patients were heterozygous (AG) and 49 patients (22.8%) were homozygous-mutated (AA). In addition to alterations in the bacterial pattern, especially in heterozygous carriers, patients with mutated alleles had a marked increase in the frequency of biliary Candida infections (P\xa0=\xa00.025). Further, patients with mutated alleles showed an increased frequency of episodes of cholangitis (P\xa0=\xa00.0025), development of dominant stenosis (P\xa0<\xa00.002) and a reduced actuarial transplantation-free survival (P\xa0=\xa00.044). Levels of biliary Ca19-9 were significantly elevated in the homozygous-mutated patients.'] Is fut2 genotype a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis?